$CNS SEC Filings

Filed On	Filing
15 Oct 2026	8-K: Results of Operations and Financial Condition Fifth consecutive quarter of organic growth, broadening client demand and continued execution across strategic growth initiatives
07 Oct 2026	SCHEDULE 13G/A
07 Oct 2026	SCHEDULE 13G/A
02 Oct 2026	Form 4: Dolly Lisa, Director Received 375 shares as a grant or award
02 Oct 2026	Form 4: Smith Dasha, Director Received 375 shares as a grant or award
02 Oct 2026	Form 4: Thissen Karen Wilson, Director Received 375 shares as a grant or award
02 Oct 2026	Form 4: Aggarwal Reena, Director Received 375 shares as a grant or award
02 Oct 2026	Form 4: Connor Frank T, Director Received 375 shares as a grant or award
02 Oct 2026	Form 4: Villani Edmond D, Director Received 375 shares as a grant or award · Gave 442 shares as a gift · Acquired 442 shares (Gift)
02 Oct 2026	Form 4: Cohen Martin, Director Received 375 shares as a grant or award
21 Aug 2026	Form 4: Poli Francis C, GC, Secretary, EVP Received 198 shares as a grant or award
21 Aug 2026	Form 4: Derechin Adam M, Chief Operating Officer, EVP Received 200 shares as a grant or award
21 Aug 2026	Form 4: Muni Amit, Chief Financial Officer, EVP Received 95 shares as a grant or award
21 Aug 2026	Form 4: Brown Brandon, Executive Vice President Received 104 shares as a grant or award
21 Aug 2026	Form 4: Noonan Daniel, Executive Vice President Received 215 shares as a grant or award
21 Aug 2026	Form 4: Cheigh Jon, President and CIO Received 715 shares as a grant or award
21 Aug 2026	Form 4: Harvey Joseph M, Director Received 1,338 shares as a grant or award
21 Aug 2026	Form 4: Dulik Elena, Chief Accounting Officer, SVP Received 39 shares as a grant or award
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A

Comments